Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Repligen Corporation

Market Cap 7.45B 6.49B 6.01B 5.63B 10.54B 702B 10.62B 71.3B 27.63B 346B 27.95B 27.35B 1,201B P/E 2026 *
121x
P/E 2027 * 73.5x
Enterprise Value 7.19B 6.27B 5.8B 5.44B 10.18B 678B 10.26B 68.86B 26.68B 334B 26.99B 26.42B 1,160B EV / Sales 2026 *
8.74x
EV / Sales 2027 * 7.42x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week-0.98%
Current month+6.51%
1 month+26.70%
3 months+12.27%
6 months-16.29%
Current year-19.43%
1 week 127.48
Extreme 127.48
136.54
1 month 103.63
Extreme 103.63
136.54
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 21.45
Extreme 21.45
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-0.98%+12.32%-16.16% 7.45B
-0.10%-1.38%-33.23%-16.75% 154B
+1.54%-1.23%-7.45%-11.00% 102B
-4.45%+6.22%+58.91%+55.60% 59.25B
-1.90%-3.43%-8.40%+48.53% 52.89B
+1.67%-2.29%-14.60%-44.33% 39.67B
-1.32%-3.20% - - 30.39B
+1.74%-3.69%-10.54%-44.30% 27.96B
+1.35%-0.72%+50.47%-9.42% 23.17B
-1.53%-1.74%-15.43%-3.81% 20.7B
Average -0.42%-0.55%+3.56%-4.63% 51.73B
Weighted average by Cap. -0.30%-0.21%-5.67%-2.58%

Financials

2026 *2027 *
Net sales 823M 718M 664M 622M 1.16B 77.62B 1.17B 7.88B 3.05B 38.21B 3.09B 3.02B 133B 945M 824M 762M 714M 1.34B 89.13B 1.35B 9.05B 3.51B 43.88B 3.55B 3.47B 152B
Net income 61.09M 53.27M 49.26M 46.17M 86.44M 5.76B 87.14M 585M 227M 2.84B 229M 224M 9.85B 101M 88.22M 81.59M 76.46M 143M 9.54B 144M 969M 375M 4.7B 380M 372M 16.32B
Net Debt -254M -222M -205M -192M -360M -24B -363M -2.44B -944M -11.81B -955M -934M -41.04B -432M -377M -348M -326M -611M -40.73B -616M -4.13B -1.6B -20.05B -1.62B -1.59B -69.65B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
18/06/26 132.02 $ -1.15% 1,236,920
17/06/26 133.55 $ +1.41% 1,352,544
16/06/26 131.69 $ +0.63% 612,354
15/06/26 130.87 $ +0.21% 633,247
12/06/26 130.59 $ -2.06% 1,338,022
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
132.02USD
Average target price
176.11USD
Spread / Average Target
+33.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!